Evidence map›Paper›PMID 33106839›Full record

ArticleBlood2021

Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations.

Wenjian Yang, Meenakshi Devidas, Yiwei Liu, Colton Smith, Yunfeng Dai, Naomi Winick, Stephen P Hunger, Mignon L Loh, Elizabeth A Raetz, Eric C Larsen and 6 more

Open access · bronzeAbstract readLetter
In one paragraph

Article in Blood, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Novel Therapeutic Approaches in Pediatric Acute Lymphoblastic Leukemia.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 1 country.

Wenjian YangDepartment of Pharmaceutical Sciences and.
Meenakshi DevidasDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN.
Yiwei LiuDepartment of Pharmaceutical Sciences and.
Colton SmithDepartment of Pharmaceutical Sciences and.
Yunfeng DaiDepartment of Biostatistics, University of Florida, Gainesville, FL.
Naomi WinickDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX.
Stephen P HungerDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
Mignon L LohDepartment of Pediatrics, University of California School of Medicine, San Francisco, CA.
Elizabeth A RaetzDepartment of Pediatrics, NYU Grossman School of Medicine, New York, NY.
Eric C LarsenDepartment of Pediatrics, Maine Medical Center, Portland, ME.
William L CarrollDepartment of Pediatrics, NYU Grossman School of Medicine, New York, NY.
Stuart S WinterChildren's Minnesota Cancer and Blood Disorders Program, Children's Minnesota, Minneapolis, MN.
Kimberly P DunsmoreDepartment of Pediatrics, Carilion Clinic, Roanoke, VA.
Leonard A MattanoHARP Pharma Consulting, Mystic, CT; and.
Mary V RellingDepartment of Pharmaceutical Sciences and.
Seth E KarolDepartment of Oncology, St Jude Children's Research Hospital, Memphis, TN.
New York University · USSt. Jude Children's Research Hospital · USCarilion Clinic · USChildren's Hospital of Philadelphia · USChildren’s Minnesota - St. Paul Hospital · USMaine Medical Center · USThe University of Texas Southwestern Medical Center · USUniversity of California, San Francisco · USUniversity of Florida · US

Funding

NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6M
Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Gregory Armstrong · 1985 to 2026
$166.9M
COG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8M
CPML - Project 3: Genome-wide Studies of Adverse EffectsP50GM115279 · NIGMS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI LOH, MIGNON LEE-CHEUN, RELLING, MARY V · 2015 to 2019
$15.1M
Glucocorticoids in Lymphoblastic LeukemiaR01CA142665 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RELLING, MARY V · 2010 to 2020
$4.6M
Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic LeukemiaK08CA250418 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KAROL, SETH EVAN · 2020 to 2024
$1.1M
NCI NIH HHS K08 CA250418NCI NIH HHS P30 CA021765NCI NIH HHS R01 CA142665NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NIGMS NIH HHS P50 GM115279
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentChildGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansOsteonecrosisPolymorphism, Single NucleotidePrecursor Cell Lymphoblastic Leukemia-Lymphoma

Identifiers

PMID33106839
PMCPMC7976510
OpenAlexW3093525250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.